Concepedia

Christopher Su

CS

18

Publications

758

Citations

14

H-Index

2014

Active since

Affiliations

University of Michigan(Current)

Dana-Farber Cancer Institute

Fred Hutch Cancer Center

University of Washington

University of California, San Francisco

Christopher Su is an author at University of Michigan specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2014–2024

18

Publications

18

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah et al. · JAMA Oncology · 2021 · 184 citations · Full text

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma

Praful Ravi, Charlene Mantia, Christopher Su et al. · JAMA Oncology · 2020 · 120 citations · Full text

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 80 citations · Full text

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Ziad Bakouny, Chris Labaki, Punita Grover et al. · JAMA Oncology · 2022 · 62 citations · Full text

Differential Activity of PARP Inhibitors in<i>BRCA1</i>- Versus<i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer

Fadi Taza, Albert Holler, Wei Fu et al. · JCO Precision Oncology · 2021 · 41 citations · Full text

Rows per page

1–5 of 18